Obesity

Early Pregnancy Plasma Per- and Polyfluoroalkyl Substances (PFAS) and Maternal Midlife Adiposity

J Clin Endocrinol MetabPublished Prospective cohort study

Authors' conclusion

Select PFAS, assessed in pregnancy, may differentially affect maternal midlife adiposity, influencing later-life maternal cardiometabolic health.

Study context

Population
Project Viva participants with early pregnancy plasma concentrations of 6 PFAS (mean gestation 10.0 weeks; mean age 32.5 years) and midlife adiposity outcomes (mean age 50.7 years)
Participants
547 participants
Exposure
Early pregnancy plasma PFAS concentrations (individual and mixture) and maternal midlife adiposity
Outcome
Midlife adiposity: weight, WC, trunk fat mass (TFM), total body fat mass (TBFM)
Follow-up
Mean 17.7 years
Methodological detailsProject Viva, linear regression, Bayesian Kernel Machine Regression (BKMR)
  • Project Viva
  • Linear regression
  • Bayesian Kernel Machine Regression (BKMR)

Main finding

As reported in the abstract

Midlife adiposity
Linear regression, weight per doubling of perfluorooctane sulfonate (PFOS)
3.8 kg (95% CI: 1.6, 5.9)
Linear regression, weight per doubling of 2-(N-ethyl-perfluorooctane sulfonamido) acetate
2.3 kg (95% CI: 0.9, 3.7)
BKMR, PFOS 25th vs 75th percentile, weight
7.7 kg (95% CI: 4.0, 11.5)
BKMR, PFOS, trunk fat mass (TFM)
1.2 kg (95% CI: 0.0, 2.3)
BKMR, PFOS, total body fat mass (TBFM)
3.0 kg (95% CI: 0.8, 5.2)
BKMR, perfluorononanoate, weight
−6.0 kg (95% CI: −8.5, −3.5)
BKMR, perfluorononanoate, waist circumference (WC)
−1.8 cm (95% CI: −3.2, −0.3)
BKMR, perfluorononanoate, TFM
−0.8 kg (95% CI: −1.5, −0.1)
BKMR, perfluorononanoate, TBFM
−1.4 kg (95% CI: −2.7, −0.3)
BKMR, perfluorohexane sulfonate, TFM
−0.8 kg (95% CI: −1.5, −0.1)
BKMR, perfluorohexane sulfonate, TBFM
−1.4 kg (95% CI: −2.6, −0.2)

Observational data: associations, not effects.

Original publication

Early Pregnancy Plasma Per- and Polyfluoroalkyl Substances (PFAS) and Maternal Midlife Adiposity. J Clin Endocrinol Metab. Published 5 September 2024. doi:10.1210/clinem/dgae542

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.